Visine
From Wikipedia, the free encyclopedia
Visine® is a brand of eye drops produced by Pfizer Inc.
Contents |
[edit] Visine® Original
The active ingredient in the original Visine® formulation is tetrahydrozoline hydrochloride which is a vasoconstrictor, and therefore constricts the eye's superficial blood vessels to "get the red out", as claimed in Pfizer's advertising[1].
[edit] Administration
As with other eye drops, Visine® is administered topically with 1 to 2 drops applied to the affected eye(s) up to 4 times daily [citation needed].
[edit] Adverse effects
- Reducing the blood supply to the eye can prevent, or at least prolong, the healing cycle. Thus, the use of Visine® and other similar products is not helpful in healing the eyes [citation needed].
- Use will create a rebound after a couple of hours and make the eye look even redder. Prolonged use can permanently dilate blood vessels, so use should be limited to 1 or 2 times.
- Those using Visine® Original frequently report stinging and burning upon application[1].
- Although the use of Visine® as a poison to induce diarrhea has been discounted as an urban legend[2], systemic complications have been reported as a result of poisoning and accidental ingestion[2][3][4].
[edit] References
- ^ Skilling FC Jr, Weaver TA, Kato KP, Ford JG, Dussia EM. "Effects of two eye drop products on computer users with subjective ocular discomfort." Optometry. 2005 Jan;76(1):47-54. PMID 15682562.
- ^ Daggy A, Kaplan R, Roberge R, Akhtar J. "Pediatric Visine (tetrahydrozoline) ingestion: case report and review of imidazoline toxicity." Vet Hum Toxicol. 2003 Aug;45(4):210-2. PMID 12882493.
- ^ Tobias JD. "Central nervous system depression following accidental ingestion of Visine eye drops." Clin Pediatr (Phila). 1996 Oct;35(10):539-40. PMID 8902333.
- ^ Lev R, Clark RF. "Visine overdose: case report of an adult with hemodynamic compromise." J Emerg Med. 1995 Sep-Oct;13(5):649-52. PMID 8530784.